Click it and Unblock the Notifications
Just In
Don't Miss
-
Pavi Caretaker X Review: Dileep-Led Comedy Drama Directed By Vineeth Kumar Promises To Be Delightful -
Who Won Yesterday's IPL Match 41? SRH vs RCB, IPL 2024 on April 25: Royal Challengers Bangalore End Losing Streak -
Bajaj Group Stock Declares Rs. 60/Share Dividend: Buy Ahead of Record Date On 28 June? -
Royal Enfield Unveils Revolutionary Rentals & Tours Service: Check Out All Details Here -
Elon Musk’s X Is Launching a TV App Similar to YouTube for Watching Videos -
AICTE introduces career portal for 3 million students, offering fully-sponsored trip to Silicon Valley -
Heeramandi Screening: Alia Bhatt, Ananya Panday, Rashmika Mandanna And Others Serve Finest Ethnic Style! -
Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
Quota for COVID-19 vaccine: Here is what Poonawalla said
New Delhi, July 27: Serum Institute of India (SII) chief executive officer (CEO) Adar Poonawalla said 'more than enough" doses of coronavirus vaccine will be reserved for the Parsi community while in responding to Screwvala tweet on COVID-19 vaccine.
Popular entrepreneur and philanthropist, Rohinton Soli aka "Ronnie" Screwvala Yesterday tweeted asking to make quota for people when it comes to COVID-19 vaccine.
Screwvala wrote, Parsis should be given the vaccine before everyone else as the people in community are less in number today.
So government or the medical team of India should folllow quota system while delievering vaccine once it come out.
Recommended Video
"On a lighter note Smiling face with smiling eyes-since Parsi's are to be an Extinct race Smiling face with smiling eyes(though avg age of Parsi's show otherwise) there is a lobby that as vaccine does come in there will be a special Quota under saving from extinction RaceSmiling face with smiling eyes-&why not if a Parsi is at the forefront of it @adarpoonawalla", reads Screwvala's tweet.
To
the
reply
of
his
tweet
the
CEO
of
Serum
Institute
of
India
told,
"Yes,
@RonnieScrewvala
,
we
will
keep
more
than
enough
for
the
community.
Our
production
capacity
of
just
one
day
will
be
enough
to
cover
every
Parsi
on
the
planet...given
the
size
of
our
community!"
Serum
Institute
of
India
(SII),
which
has
partnered
with
AstraZeneca
for
manufacturing
the
Oxford
vaccine
candidate
for
COVID-19,
has
sought
permission
from
the
Drugs
Controller
General
of
India
(DCGI)
for
conducting
phase
2
and
3
human
clinical
trials
of
the
potential
vaccine,
according
to
report.
